Objective: The purpose of the study is to evaluate the causative organ
isms, treatment methods, and visual acuity outcomes of patients treate
d for delayed-onset endophthalmitis associated with conjunctival filte
ring blebs. Methods: The medical records of 32 patients with conjuncti
val filtering bleb-associated endophthalmitis treated at the Bascom Pa
lmer Eye Institute between 1989 and 1995 were reviewed retrospectively
. Bleb-associated endophthalmitis was diagnosed at 1 month or more aft
er surgery in all patients. Patients with bleb infections only but wit
hout signs of intraocular infection were excluded from this series. Re
sults: Previous antimetabolite therapy was used in 20 patients, includ
ing mitomycin C in 14 and 5-fluorouracil in 6. Streptococcal species w
ere the most frequently cultured organisms occurring in 15 (47%) of 32
eyes. Of the 32 patients, 30 received intraocular antibiotics. The in
itial treatment included a pars plana vitrectomy in 18 patients and a
vitreous tap without vitrectomy in 12 patients. Two of three patients
who presented with no light perception vision were treated by eviscera
tion. Overall, 15 (47%) of 32 patients achieved a final visual acuity
of 20/400 or better. Of those patients with Streptococcal species cult
ured from the eye, 6 (40%) of 15 had a visual acuity of 20/400 or bett
er compared to 9 (52%) of 17 in patients with non-Streptococcal specie
s. Conclusions: Delayed-onset endophthalmitis associated with conjunct
ival filtering blebs is a current and future concern, especially with
increasing use of mitomycin C. The Streptococcal species are a common
causative organism. Despite current treatment of these patients, the v
isual acuity outcomes generally are worse than in patients with acute-
onset endophthalmitis after cataract surgery.